News ZIM Laboratories Limited

Stocks

ZIMLAB

INE518E01015

Pharmaceuticals

Market Closed - Bombay S.E. 06:03:20 2026-09-10 EDT			5-day change	1st Jan Change
136.65 ^INR	+2.78%		+2.28%	+90.08%

08-07	ZIM Laboratories Limited, Q1 2027 Earnings Call, Aug 07, 2026
08-06	ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

All News

Mentions Relevance

08-07	ZIM Laboratories Limited, Q1 2027 Earnings Call, Aug 07, 2026
08-06	ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-20	ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026
05-20	ZIM Laboratories' Consolidated Profit Declines in Fiscal Q4; Shares Slide 4%	MT
05-19	Zim Laboratories gets marketing authorization for dabigatran etexilate capsules in Italy, Europe	RE
05-19	ZIM Laboratories Limited Announces Grant of Marketing Authorization (MA) for Dabigatran Etexilate (75 Mg, 110 Mg & 150 Mg) Capsules in Italy, Europe	CI
05-19	ZIM Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-19	Zim Laboratories March-quarter consol net profit 37.4 mln rupees	RE
03-13	ZIM Laboratories Limited announced that it has received INR 349.99995 million in funding from Florintree Trinex LLP	CI
02-13	ZIM Laboratories Limited, Q3 2026 Earnings Call, Feb 13, 2026
02-12	ZIM Laboratories To Set Up Wholly Owned Subsidiary In Chile	MT
02-12	ZIM Laboratories Posts Higher Consolidated Profit Climbs in Fiscal Q3	MT
02-11	ZIM Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-02	ZIM Laboratories Limited Announces Executive Changes, Effective February 2, 2026	CI
01-21	ZIM Laboratories Limited announced that it expects to receive INR 349.99995 million in funding	CI
01-15	Zim Laboratories to consider fund raising via securities issuance	RE
12-03	ZIM Laboratories Gets Indian Regulator's Nod for Naproxen + Esomeprazole Capsules	MT
12-03	ZIM Laboratories Limited Receives Approval from Central Drugs Standard Control Organization	CI
11-14	ZIM Laboratories Limited, Q2 2026 Earnings Call, Nov 14, 2025
11-12	ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-08-12	ZIM Laboratories Limited, Q1 2026 Earnings Call, Aug 12, 2025
25-08-07	ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-08-07	ZIM Laboratories Limited Approves Closure of ZIM Laboratories Middle East DMCC	CI
25-08-04	Zim Laboratories gets marketing authorization for Tamsulosin + Dutasteride capsules in Australia	RE
25-08-04	ZIM Laboratories Limited Receives Marketing Authorization for Tamsulosin Hydrochloride and Dutasteride Capsules in Australia	CI